New York, October 1 (FinanceEnquiry.com) – Analysts at Bank of America Merrill Lynch reiterate their NEUTRAL rating on the shares of Boston Scientific Corporation (NYSE: BSX). The 12-month price objective has been reduced from $8.50 to $6.30.
In a research note published on September 28, the analysts mention that more confidence is needed on the topic that Boston Scientific can develop. Furthermore, so to permit for operating leverage, more assurance is needed that falls of ASP in the core drug-eluting stent market of the company will moderate and the Promus Element stent can be unbeaten in the US for being more bullish on Boston Scientific Corporation.
In addition to this, despite the fact that plan of BSX’s management to play out is waited, it would be very easier to call Boston Scientific Corporation inexpensive and to fight that an optimistic risk or reward exists if convincing attitude is carried on the subject of operating leverage that it will be materialized. Moreover, on September 27, Boston Scientific Corporation was closed at $5.66, the analysts add further.
New York, March 1 (FinanceEnquiry.com) – Analyst Eric Katzman at Deutsche Bank Securities reiterates BUY rating on the shares of Dean Foods (NYSE: DF). The 12-month target price is set to $21.
In a...
New York, February 28 (FinanceEnquiry.com) – Seeing that Federal Reserve Chairman Ben Bernanke stayed unwavering in supporting the stimulus policy of Fed and data signaled to economic development, stocks...
New York, February 27 (FinanceEnquiry.com) – Analyst Joshua Shanker at Deutsche Bank Securities reiterates BUY rating on the shares of American International Group, Inc (NYSE: AIG). The 12-month target price has...
New York, February 26 (FinanceEnquiry.com) – Analysts at Deutsche Bank Securities reiterate their BUY rating on the shares of Portland General Electric Company (NYSE: POR). The 12-month...
New York, December 28 (FinanceEnquiry.com) – Striking a low of four-month as a looming fiscal crisis sapped what had been a rising sense of sanguinity on the subject of the economy, US customer...
New York, December 27 (FinanceEnquiry.com) – Analysts at Citigroup reiterate their BUY rating on the shares of Carnival Corporation (NYSE: CCL). The 12-month target price is set to $44.
In a...
New York, December 26 (FinanceEnquiry.com) – Analysts at Deutsche Bank Securities reiterate their BUY rating on the shares of TripAdvisor Inc (NASDAQ: TRIP). The 12-month target price is set to...
New York, December 24 (FinanceEnquiry.com) – Analysts at JP Morgan reiterate their OVERWEIGHT rating on the shares of The Carlyle Group (NASDAQ: CG). The 12-month target price has been raised to some...
New York, December 24 (FinanceEnquiry.com) – Analysts at Taglich Brothers reiterate their SPECULATIVE BUY rating on the shares of Sonic Foundry (NASDAQ: SOFO). The 12-month target price has been reduced...
New York, December 21 (FinanceEnquiry.com) – Analysts at Deutsche Bank Securities report on Retailing / Hardlines - Hardline Headlines.
In a research note published on December 17, the analysts mention that...
